Calcium and vitamin D nutrient deficiencies lead to higher risk for osteoporosis

July 28, 2020

Pharmavite LLC, the makers of Nature Made vitamins, minerals and supplements, announced the publication of a research article in the journal PLoS ONE, which examines inadequate nutrient intake and its relationship to poor bone health, specifically risk of osteoporosis. The research was a cross sectional analysis of the U.S population [from National Health and Nutrition Examination Survey (NHANES) data], with a specific focus on those below the poverty line with food insecurities.

Poverty can be a barrier to routinely acquiring adequate nutrient intakes, specifically for calcium and vitamin D, to ensure bone health with the ultimate goal of preventing of osteoporosis. Age, gender and dietary intake are major factors that contribute to osteoporosis prevalence. This study examined the relationship between markers of poverty with calcium and vitamin D intake and osteoporosis in Americans, 50 years and older.

"This study continues to demonstrate how prevalent nutrient deficiency is among the U.S. population, and even more so, among lower income individuals and those with food insecurities. Yet, we know that nutrient adequacy is imperative in supporting overall health and wellness, including immune health, at a time when that is heavy on everyone's mind," said Susan Hazels Mitmesser, PhD, Vice President of Science & Technology at Pharmavite.

In the U.S., 25% of older Americans live below the poverty line. Within this population, 68% have inadequate calcium intakes, and 46% have inadequate vitamin D intakes. Gender, ethnic, and socio-economic differences impact overall risk for inadequate calcium and vitamin D intakes and subsequent osteoporosis risk, as seen in some of the study key findings:

• American women over the age of 50 consistently have inadequate calcium intake regardless of their economic status.
• Inadequate intake of calcium and vitamin D affects poverty-stricken men more than women with respect to osteoporosis risk.
• Non-Hispanic Black men with a low income have two times greater risk for developing osteoporosis.
  
  "Improving the consumption of nutrient-rich and fortified foods among individuals that live in poverty can help to decrease their chances of developing osteoporosis. Additionally, dietary supplements can play a critical role in helping any underserved population meet their nutrition needs --including making supplements readily available through programs like SNAP, for example," adds Mitmesser. "Our research demonstrates that participants with SNAP benefits and more access to food, have fewer nutrient inadequacies which helps them meet their nutrition needs."
  
  It has been estimated in the U.S. population age 50 and older, about 10.2 million suffer from osteoporosis, and 80% of these affected cases are females. In addition, there are potentially 43.4 million people, or 44% of the population with osteopenia, which is a bone condition that often leads to osteoporosis. More than two million osteoporosis-related fractures occur annually, leading to more than 19 billion dollars in health care costs in the US.
  -end-
  Access the full research study, "Inadequate calcium and vitamin D intake and osteoporosis risk in older Americans living in poverty with food insecurities" here: https://doi.org/10.1371/journal.pone.0235042
  
  About Pharmavite LLC
  
  Pharmavite is a leader in the health and wellness industry, earning the trust of healthcare professionals, consumers, and retailers by manufacturing high-quality nutrition products and solutions under its Nature Made®, MegaFood, EQUELLE® and nurish by Nature Made brands. Pharmavite is dedicated to helping people live healthier, more vital lives by producing the highest quality products and providing trust and transparency. Based in California, Pharmavite LLC is a subsidiary of Otsuka Pharmaceutical Co., Ltd. Visit http://www.pharmavite.com for more information.
  
  Pharmavite LLC
  
  

  Related Osteoporosis Articles from Brightsurf:

  New opportunities for detecting osteoporosis
  Osteoporosis can be detected through low dose computed tomography (LDCT) imaging tests performed for lung cancer screening or other purposes.
  
  Oxytocin can help prevent osteoporosis
  In a laboratory experiment with rats, Brazilian researchers succeeded in reversing natural processes associated with aging that lead to loss of bone density and strength.
  
  New strategy against osteoporosis
  An international research team has found a new approach that may be able to reduce bone loss in osteoporosis and maintain bone health.
  
  New review on management of osteoporosis in premenopausal women
  An IOF and ECTS Working Group have published an updated review of literature published after 2017 on premenopausal osteoporosis.
  
  Cardiac CT can double as osteoporosis test
  Cardiac CT exams performed to assess heart health also provide an effective way to screen for osteoporosis, potentially speeding treatment to the previously undiagnosed, according to a new study.
  
  Osteoporosis treatment may also protect against pneumonia
  A recent study published in the Journal of Bone and Mineral Research found that nitrogen-containing bisphosphonates (N-BPs) such as alendronate, which are widely used to treat postmenopausal osteoporosis, are linked with lower risks of pneumonia and of dying from pneumonia.
  
  New pharmaceutical target reverses osteoporosis in mice
  Biomedical engineers at Duke University have discovered that an adenosine receptor called A2B can be pharmaceutically activated to reverse bone degradation caused by osteoporosis in mouse models of the disease.
  
  A link between mitochondrial damage and osteoporosis
  In healthy people, a tightly controlled process balances out the activity of osteoblasts, which build bone, and osteoclasts, which break it down.
  
  Many stroke patients not screened for osteoporosis, despite known risks
  Many stroke survivors have an increased risk of osteoporosis, falls or breaks when compared to healthy people.
  
  Many postmenopausal women do not receive treatment for osteoporosis
  The benefits of treating osteoporosis in postmenopausal women outweigh the perceived risks, according to a Clinical Practice Guideline issued today by the Endocrine Society.
  
  Read More: Osteoporosis News and Osteoporosis Current Events